Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells ; volume:8 ; number:1 ; day:22 ; month:10 ; year:2018 ; pages:1-12 ; date:12.2018
Scientific reports ; 8, Heft 1 (22.10.2018), 1-12, 12.2018
- Creator
-
Pokrishevsky, Edward
- Contributor
-
McAlary, Luke
Farrawell, Natalie E.
Zhao, Beibei
Sher, Mine
Yerbury, Justin J.
Cashman, Neil R.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-32835-y
- URN
-
urn:nbn:de:101:1-2018112123451982497285
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pokrishevsky, Edward
- McAlary, Luke
- Farrawell, Natalie E.
- Zhao, Beibei
- Sher, Mine
- Yerbury, Justin J.
- Cashman, Neil R.
- SpringerLink (Online service)
Other Objects (12)
Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
Aggregation‐Induced Enhanced Emission of a Dimethylacridan Substituted Pyrimidine Derivative
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
PolyQ aggregation studied by model peptides with intrinsic tryptophan fluorophores
Aggregate-selective antibody attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice
Cyclopropanierung substituierter Pyrimidine
Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
Der Einfluss einer wildtypischen SOD1-Untereinheit auf Konformation und Stabilität mutanter SOD1-Heterodimere
Der Einfluss einer wildtypischen SOD1-Untereinheit auf Konformation und Stabilität mutanter SOD1-Heterodimere
Die Beteiligung von wildtypischer SOD1 an der Pathogenese der SOD1-vermittelten amyotrophen Lateralsklerose (ALS1)
Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
Aggregation‐Induced Enhanced Emission of a Dimethylacridan Substituted Pyrimidine Derivative
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
PolyQ aggregation studied by model peptides with intrinsic tryptophan fluorophores
Aggregate-selective antibody attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice
Cyclopropanierung substituierter Pyrimidine
Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
Der Einfluss einer wildtypischen SOD1-Untereinheit auf Konformation und Stabilität mutanter SOD1-Heterodimere
Der Einfluss einer wildtypischen SOD1-Untereinheit auf Konformation und Stabilität mutanter SOD1-Heterodimere
Die Beteiligung von wildtypischer SOD1 an der Pathogenese der SOD1-vermittelten amyotrophen Lateralsklerose (ALS1)
Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
Aggregation‐Induced Enhanced Emission of a Dimethylacridan Substituted Pyrimidine Derivative
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
PolyQ aggregation studied by model peptides with intrinsic tryptophan fluorophores
Aggregate-selective antibody attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice
Cyclopropanierung substituierter Pyrimidine
Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
Der Einfluss einer wildtypischen SOD1-Untereinheit auf Konformation und Stabilität mutanter SOD1-Heterodimere
Der Einfluss einer wildtypischen SOD1-Untereinheit auf Konformation und Stabilität mutanter SOD1-Heterodimere